Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 406

1.

Tissue amino acid profiles are characteristic of tumor type, malignant phenotype, and tumor progression in pancreatic tumors.

Hiraoka N, Toue S, Okamoto C, Kikuchi S, Ino Y, Yamazaki-Itoh R, Esaki M, Nara S, Kishi Y, Imaizumi A, Ono N, Shimada K.

Sci Rep. 2019 Jul 8;9(1):9816. doi: 10.1038/s41598-019-46404-4.

2.

Characterizing the Effect of Automated Cell Sorting Solutions on Cytomorphological Changes.

Ikeda K, Sato S, Chigira H, Shibuki Y, Hiraoka N.

Acta Cytol. 2019 Jun 24:1-9. doi: 10.1159/000500769. [Epub ahead of print]

PMID:
31234180
3.

Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.

Kishi Y, Nara S, Esaki M, Hiraoka N, Shimada K.

BJS Open. 2019 Jan 24;3(3):327-335. doi: 10.1002/bjs5.50130. eCollection 2019 Jun.

4.

Feasibility of genomic profiling with next-generation sequencing using specimens obtained by image-guided percutaneous needle biopsy.

Sone M, Arai Y, Sugawara S, Kubo T, Itou C, Hasegawa T, Umakoshi N, Yamamoto N, Sunami K, Hiraoka N, Kubo T.

Ups J Med Sci. 2019 Apr;124(2):119-124. doi: 10.1080/03009734.2019.1607635.

5.

A Single-Institution Validation Study of Lymph Node Staging By the AJCC 8th Edition for Patients with Pancreatic Head Cancer: A Proposal to Subdivide the N2 Category.

Asano D, Nara S, Kishi Y, Esaki M, Hiraoka N, Tanabe M, Shimada K.

Ann Surg Oncol. 2019 Jul;26(7):2112-2120. doi: 10.1245/s10434-019-07390-z. Epub 2019 Apr 29.

PMID:
31037440
6.

Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.

Saito Y, Muramatsu T, Kanai Y, Ojima H, Sukeda A, Hiraoka N, Arai E, Sugiyama Y, Matsuzaki J, Uchida R, Yoshikawa N, Furukawa R, Saito H.

Cell Rep. 2019 Apr 23;27(4):1265-1276.e4. doi: 10.1016/j.celrep.2019.03.088.

7.

Local Administration of GITR Agonistic Antibody Induces a Stronger Antitumor Immunity than Systemic Delivery.

Narumi K, Miyakawa R, Shibasaki C, Henmi M, Mizoguchi Y, Ueda R, Hashimoto H, Hiraoka N, Yoshida T, Aoki K.

Sci Rep. 2019 Apr 3;9(1):5562. doi: 10.1038/s41598-019-41724-x.

8.

Association between preexisting lung involvements and the risk of diffuse alveolar hemorrhage in patients with microscopic polyangiitis: A multi-center retrospective cohort study.

Kida T, Tanaka T, Yokota I, Tamagaki K, Sagawa T, Kadoya M, Yamada T, Fujioka K, Wada M, Kohno M, Hiraoka N, Omoto A, Fukuda W, Kawahito Y.

Mod Rheumatol. 2019 Apr 1:1-7. doi: 10.1080/14397595.2019.1601855. [Epub ahead of print]

PMID:
30929541
9.

All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma.

Kobayashi K, Yoshimoto S, Matsumoto F, Ando M, Murakami N, Omura G, Fukasawa M, Matsumoto Y, Matsumura S, Akamatsu M, Hiraoka N, Eigitsu R, Mori T.

Ann Surg Oncol. 2019 Jul;26(7):2294-2303. doi: 10.1245/s10434-019-07287-x. Epub 2019 Mar 21.

PMID:
30900104
10.

Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.

Teshima M, Tokita K, Ryo E, Matsumoto F, Kondo M, Ikegami Y, Shinomiya H, Otsuki N, Hiraoka N, Nibu KI, Yoshimoto S, Mori T.

BMC Cancer. 2019 Mar 18;19(1):245. doi: 10.1186/s12885-019-5452-4.

11.

Reliable evaluation of tumor-infiltrating lymphocytes in pancreatic cancer tissue biopsies.

Ino Y, Oguro S, Yamazaki-Itoh R, Hori S, Shimada K, Hiraoka N.

Oncotarget. 2019 Feb 1;10(10):1149-1159. doi: 10.18632/oncotarget.26646. eCollection 2019 Feb 1.

12.

Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma.

Iwasaki T, Hiraoka N, Ino Y, Nakajima K, Kishi Y, Nara S, Esaki M, Shimada K, Katai H.

Cancer Sci. 2019 Apr;110(4):1491-1502. doi: 10.1111/cas.13975. Epub 2019 Mar 19.

13.

Two rare cases of endosalpingiosis in the axillary sentinel lymph nodes: evaluation of immunohistochemical staining and one-step nucleic acid amplification (OSNA) assay in patients with breast cancer.

Shiino S, Yoshida M, Jimbo K, Asaga S, Takayama S, Maeshima A, Tsuda H, Kinoshita T, Hiraoka N.

Virchows Arch. 2019 May;474(5):633-638. doi: 10.1007/s00428-019-02521-z. Epub 2019 Feb 12.

PMID:
30756183
14.

Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study.

Sunami K, Ichikawa H, Kubo T, Kato M, Fujiwara Y, Shimomura A, Koyama T, Kakishima H, Kitami M, Matsushita H, Furukawa E, Narushima D, Nagai M, Taniguchi H, Motoi N, Sekine S, Maeshima A, Mori T, Watanabe R, Yoshida M, Yoshida A, Yoshida H, Satomi K, Sukeda A, Hashimoto T, Shimizu T, Iwasa S, Yonemori K, Kato K, Morizane C, Ogawa C, Tanabe N, Sugano K, Hiraoka N, Tamura K, Yoshida T, Fujiwara Y, Ochiai A, Yamamoto N, Kohno T.

Cancer Sci. 2019 Apr;110(4):1480-1490. doi: 10.1111/cas.13969. Epub 2019 Apr 2.

15.

Plasmons in Li under compression.

Matsuoka T, Ibañez-Azpiroz J, Hiraoka N, Fukui H, Bergara A.

J Phys Condens Matter. 2019 May 8;31(18):185501. doi: 10.1088/1361-648X/ab0528. Epub 2019 Feb 7.

PMID:
30731441
16.

Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis.

Yoshimura A, Yamada T, Tsuji T, Hamashima R, Shiotsu S, Yuba T, Takumi C, Uchino J, Hiraoka N, Takayama K.

Thorac Cancer. 2019 Mar;10(3):557-563. doi: 10.1111/1759-7714.12979. Epub 2019 Jan 23.

17.

Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.

Nakao A, Hiranuma O, Uchino J, Sakaguchi C, Kita T, Hiraoka N, Ishizuka T, Kubota Y, Kawasaki M, Goto Y, Imai H, Hattori N, Nakatomi K, Uramoto H, Uryu K, Fukuda M, Uchida Y, Yokoyama T, Akai M, Mio T, Nagashima S, Chihara Y, Tamiya N, Kaneko Y, Mouri T, Yamada T, Yoshimura K, Fujita M, Takayama K.

Oncologist. 2019 May;24(5):593-e170. doi: 10.1634/theoncologist.2019-0003. Epub 2019 Jan 16.

18.

Steatotic and nonsteatotic scirrhous hepatocellular carcinomas reveal distinct clinicopathological features.

Hatano M, Ojima H, Masugi Y, Tsujikawa H, Hiraoka N, Kanai Y, Shimada K, Shinoda M, Sakamoto M.

Hum Pathol. 2019 Apr;86:222-232. doi: 10.1016/j.humpath.2018.11.024. Epub 2018 Dec 28.

PMID:
30597153
19.

Invasive breast cancers in adolescent and young adult women show more aggressive immunohistochemical and clinical features than those in women aged 40-44 years.

Hironaka-Mitsuhashi A, Tsuda H, Yoshida M, Shimizu C, Asaga S, Hojo T, Tamura K, Kinoshita T, Ushijima T, Hiraoka N, Fujiwara Y.

Breast Cancer. 2019 May;26(3):386-396. doi: 10.1007/s12282-018-00937-0. Epub 2018 Dec 11.

PMID:
30539373
20.

Calcifying nested stromal epithelial tumor of the liver in a patient with Klinefelter syndrome: a case report and review of the literature.

Tsuruta S, Kimura N, Ishido K, Kudo D, Sato K, Endo T, Yoshizawa T, Sukeda A, Hiraoka N, Kijima H, Hakamada K.

World J Surg Oncol. 2018 Nov 19;16(1):227. doi: 10.1186/s12957-018-1528-x. Review.

21.

Identification of Stabilizing High-Valent Active Sites by Operando High-Energy Resolution Fluorescence-Detected X-ray Absorption Spectroscopy for High-Efficiency Water Oxidation.

Hung SF, Chan YT, Chang CC, Tsai MK, Liao YF, Hiraoka N, Hsu CS, Chen HM.

J Am Chem Soc. 2018 Dec 12;140(49):17263-17270. doi: 10.1021/jacs.8b10722. Epub 2018 Nov 29.

PMID:
30441896
22.

H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.

Makise N, Sekimizu M, Konishi E, Motoi T, Kubo T, Ikoma H, Watanabe SI, Okuma T, Hiraoka N, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Mod Pathol. 2019 Mar;32(3):435-445. doi: 10.1038/s41379-018-0140-5. Epub 2018 Oct 5.

PMID:
30291346
23.

An observational study of the epidermal growth factor receptor-tyrosine kinase inhibitor resistance mechanism in epidermal growth factor receptor gene mutation-positive non-small cell lung cancer.

Yoshimura A, Uchino J, Tanimura K, Chihara Y, Tamiya N, Kaneko Y, Takeda T, Hiranuma O, Hasegawa I, Kubota Y, Shiotsu S, Takumi C, Hiraoka N, Yamada T, Takayama K.

Medicine (Baltimore). 2018 Oct;97(40):e12660. doi: 10.1097/MD.0000000000012660.

24.

Frequent false-negative immunohistochemical staining with IDH1 (R132H)-specific H09 antibody on frozen section control slides: a potential pitfall in glioma diagnosis.

Yoshida A, Satomi K, Ohno M, Matsushita Y, Takahashi M, Miyakita Y, Hiraoka N, Narita Y, Ichimura K.

Histopathology. 2019 Jan;74(2):350-354. doi: 10.1111/his.13756. Epub 2018 Dec 5.

PMID:
30221786
25.

SMARCB-1 deficient squamous cell carcinoma of a mediastinal cyst.

Nishimura Y, Yoshida A, Yonemori K, Motoi N, Tamura K, Hiraoka N, Mori T.

Pathol Int. 2018 Oct;68(10):563-566. doi: 10.1111/pin.12720. Epub 2018 Sep 14. Erratum in: Pathol Int. 2018 Dec;68(12):717.

PMID:
30216599
26.

Extent of lymph node dissection in patients with gallbladder cancer.

Kishi Y, Nara S, Esaki M, Hiraoka N, Shimada K.

Br J Surg. 2018 Nov;105(12):1658-1664. doi: 10.1002/bjs.10913. Epub 2018 Jul 11.

PMID:
29993120
27.

Pulmonary pleomorphic carcinoma with pseudoprogression during nivolumab therapy and the usefulness of tumor markers: A case report.

Yoshimura A, Takumi C, Tsuji T, Hamashima R, Shiotsu S, Yuba T, Urata Y, Hiraoka N.

Clin Case Rep. 2018 May 29;6(7):1338-1341. doi: 10.1002/ccr3.1627. eCollection 2018 Jul.

28.

BK virus pneumonia following stem cell transplantation against diffuse large B-cell lymphoma.

Yoshimura A, Tsuji T, Kawaji Y, Hirakawa Y, Uchiyama H, Hiraoka N.

Respirol Case Rep. 2018 Jun 26;6(7):e00348. doi: 10.1002/rcr2.348. eCollection 2018 Oct.

29.

Evolution of a Novel Ribbon Phase in Optimally Doped Bi2Sr2CaCu2O8+δ at High Pressure and Its Implication to High- TC Superconductivity.

Zhang J, Ding Y, Chen CC, Cai Z, Chang J, Chen B, Hong X, Fluerasu A, Zhang Y, Ku CS, Brewe D, Heald S, Ishii H, Hiraoka N, Tsuei KD, Liu W, Zhang Z, Cai YQ, Gu G, Irifune T, Mao HK.

J Phys Chem Lett. 2018 Aug 2;9(15):4182-4188. doi: 10.1021/acs.jpclett.8b01849. Epub 2018 Jul 13.

PMID:
29979596
30.

Unstable behavior of segmental ring under various pressures and its discrete element simulation.

Kikkawa N, Hiraoka N, Itoh K, Orense RP.

Ind Health. 2018 Nov 21;56(6):475-484. doi: 10.2486/indhealth.2018-0049. Epub 2018 Jun 23.

31.

Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp.

Cho H, Hashimoto T, Yoshida H, Taniguchi H, Ogawa R, Mori T, Hiraoka N, Saito Y, Sekine S.

Histopathology. 2018 Oct;73(4):672-680. doi: 10.1111/his.13688. Epub 2018 Aug 2.

PMID:
29920740
32.

Superficially serrated adenoma: a proposal for a novel subtype of colorectal serrated lesion.

Hashimoto T, Tanaka Y, Ogawa R, Mori T, Yoshida H, Taniguchi H, Hiraoka N, Kojima M, Oono Y, Saito Y, Sekine S.

Mod Pathol. 2018 Oct;31(10):1588-1598. doi: 10.1038/s41379-018-0069-8. Epub 2018 May 22.

PMID:
29789649
33.

Epigenetic landscape influences the liver cancer genome architecture.

Hama N, Totoki Y, Miura F, Tatsuno K, Saito-Adachi M, Nakamura H, Arai Y, Hosoda F, Urushidate T, Ohashi S, Mukai W, Hiraoka N, Aburatani H, Ito T, Shibata T.

Nat Commun. 2018 Apr 24;9(1):1643. doi: 10.1038/s41467-018-03999-y.

34.

Gold-nanofève surface-enhanced Raman spectroscopy visualizes hypotaurine as a robust anti-oxidant consumed in cancer survival.

Shiota M, Naya M, Yamamoto T, Hishiki T, Tani T, Takahashi H, Kubo A, Koike D, Itoh M, Ohmura M, Kabe Y, Sugiura Y, Hiraoka N, Morikawa T, Takubo K, Suina K, Nagashima H, Sampetrean O, Nagano O, Saya H, Yamazoe S, Watanabe H, Suematsu M.

Nat Commun. 2018 Apr 19;9(1):1561. doi: 10.1038/s41467-018-03899-1.

35.

Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.

Tate K, Yoshida H, Ishikawa M, Uehara T, Ikeda SI, Hiraoka N, Kato T.

J Gynecol Oncol. 2018 May;29(3):e34. doi: 10.3802/jgo.2018.29.e34. Epub 2018 Feb 19.

36.

Extraskeletal osteosarcoma: MDM2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity.

Makise N, Sekimizu M, Kubo T, Wakai S, Watanabe SI, Kato T, Kinoshita T, Hiraoka N, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Histopathology. 2018 Jul;73(1):147-156. doi: 10.1111/his.13506. Epub 2018 Apr 19.

PMID:
29489027
37.

Uterine adenosarcoma in Japan: Clinicopathologic features, diagnosis and management.

Tate K, Watanabe R, Yoshida H, Shimizu H, Uehara T, Ishikawa M, Ikeda SI, Hiraoka N, Kato T.

Asia Pac J Clin Oncol. 2018 Aug;14(4):318-325. doi: 10.1111/ajco.12859. Epub 2018 Feb 14.

PMID:
29441675
38.

INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma.

Yoshida A, Makise N, Wakai S, Kawai A, Hiraoka N.

Mod Pathol. 2018 May;31(5):744-752. doi: 10.1038/modpathol.2017.189. Epub 2018 Jan 12.

39.

Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.

Makise N, Sekimizu M, Kubo T, Wakai S, Hiraoka N, Komiyama M, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Am J Surg Pathol. 2018 May;42(5):656-664. doi: 10.1097/PAS.0000000000001014.

PMID:
29309298
40.

Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified.

Nakayama S, Yokote T, Akioka T, Hiraoka N, Nishiwaki U, Miyoshi T, Iwaki K, Takayama A, Masuda Y, Hatooka J, Fujimoto M, Nishimura Y, Tsuji M.

Blood Adv. 2017 Mar 6;1(8):486-493. doi: 10.1182/bloodadvances.2016000885. eCollection 2017 Mar 14.

41.

Tumor-associated CD204+ M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma.

Kawachi A, Yoshida H, Kitano S, Ino Y, Kato T, Hiraoka N.

Cancer Sci. 2018 Mar;109(3):863-870. doi: 10.1111/cas.13476. Epub 2018 Feb 2.

42.

The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy.

Shoji H, Tada K, Kitano S, Nishimura T, Shimada Y, Nagashima K, Aoki K, Hiraoka N, Honma Y, Iwasa S, Takashima A, Kato K, Boku N, Honda K, Yamada T, Heike Y, Hamaguchi T.

Oncotarget. 2017 May 30;8(56):95083-95094. doi: 10.18632/oncotarget.18297. eCollection 2017 Nov 10.

43.

Liver atrophy after percutaneous transhepatic portal embolization occurs in two histological phases: Hepatocellular atrophy followed by apoptosis.

Iwao Y, Ojima H, Kobayashi T, Kishi Y, Nara S, Esaki M, Shimada K, Hiraoka N, Tanabe M, Kanai Y.

World J Hepatol. 2017 Nov 18;9(32):1227-1238. doi: 10.4254/wjh.v9.i32.1227.

44.

A tissue microRNA signature that predicts the prognosis of breast cancer in young women.

Hironaka-Mitsuhashi A, Matsuzaki J, Takahashi RU, Yoshida M, Nezu Y, Yamamoto Y, Shiino S, Kinoshita T, Ushijima T, Hiraoka N, Shimizu C, Tamura K, Ochiya T.

PLoS One. 2017 Nov 15;12(11):e0187638. doi: 10.1371/journal.pone.0187638. eCollection 2017.

45.
46.

SOX10 Expression as Well as BRAF and GNAQ/11 Mutations Distinguish Pigmented Ciliary Epithelium Neoplasms From Uveal Melanomas.

Mori T, Sukeda A, Sekine S, Shibata S, Ryo E, Okano H, Suzuki S, Hiraoka N.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5445-5451. doi: 10.1167/iovs.17-22362.

PMID:
29059311
47.

Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors.

Yamamoto Y, Nagasato M, Rin Y, Henmi M, Ino Y, Yachida S, Ohki R, Hiraoka N, Tagawa M, Aoki K.

Cancer Med. 2017 Oct;6(10):2385-2397. doi: 10.1002/cam4.1185. Epub 2017 Sep 21.

48.

Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma.

Furukawa D, Chijiwa T, Matsuyama M, Mukai M, Matsuo EI, Nishimura O, Kawai K, Suemizu H, Nakagohri T, Ozawa S, Shimada K, Hiraoka N, Nakamura M.

Oncol Lett. 2017 Sep;14(3):3633-3640. doi: 10.3892/ol.2017.6633. Epub 2017 Jul 20.

49.

Electronic structure of ferromagnetic heavy fermion, YbPdSi, YbPdGe, and YbPtGe studied by photoelectron spectroscopy, x-ray emission spectroscopy, and DFT  +  DMFT calculations.

Yamaoka H, Thunström P, Tsujii N, Katoh K, Yamamoto Y, Schwier EF, Shimada K, Iwasawa H, Arita M, Jarrige I, Hiraoka N, Ishii H, Tsuei KD, Mizuki J.

J Phys Condens Matter. 2017 Nov 29;29(47):475502. doi: 10.1088/1361-648X/aa8b98.

PMID:
28891807
50.

Prognostic Impact of Margin Distance and Tumor Spread Through Air Spaces in Limited Resection for Primary Lung Cancer.

Masai K, Sakurai H, Sukeda A, Suzuki S, Asakura K, Nakagawa K, Asamura H, Watanabe SI, Motoi N, Hiraoka N.

J Thorac Oncol. 2017 Dec;12(12):1788-1797. doi: 10.1016/j.jtho.2017.08.015. Epub 2017 Sep 4.

Supplemental Content

Loading ...
Support Center